2/19/2024Everest Ends Covid-19 Vaccine Deal With Canada's Providence

9/20/2023Everest Medicines Enters into Collaboration and License Agreement with...

4/19/2023Everest Medicines Enters Strategic Partnership with Shanghai Pharma Su...

2/8/2023After Ditching Promising Drug, Everest Medicines Bets on mRNA (The Bam...

1/19/2023After Ditching Promising Drug, Everest Medicines Bets on mRNA (The Bam...

12/28/2022Everest Medicines Begins Operations at mRNA Vaccine Production Site in...

8/17/2022Gilead to Acquire Remaining Worldwide Rights of Trodelvy from Everest ...

4/6/2022Everest Med Enters into an MOU for Partnership with CR Pharma for its ...

1/17/2022Everest Med and EDDC Enter Global Deal for Latter's 3CL Protease In...

12/14/2021Everest Med and Providence Therapeutics Join Hands to Co-develop Vacci...

11/11/2021Everest Med and Gilead Announce P2b Study of Sacituzumab Govitecan in ...

9/24/2021Everest Medicines Announces IND Approval of Class 1 Anti-infective SPR...

9/16/2021Everest Medicines, Sinovent and SinoMab Enter Licensing Deal for Novel...

9/13/2021Everest Licesens Select Asian Rights of Providence's mRNA COVID Vaccin...

8/5/2021Everest Med Granted Chinese CTA for Phase 3 Trial of Xerava for CABP

7/13/2021Everest Medicines and Tencent Enters Strategic Commercial Partnership

5/17/2021Everest Med's BLA for Sacituzumab Govitecan-Hziy Accepted in China 

3/31/2021Everest Medicines Granted Clinical Trial Approval to Evaluate Trodelv...

3/23/2021Everest Med Files NDA for cIAI Drug Xerava (Eravacycline) in China

1/22/2021Everest Medicines Granted Clinical Trial Approval of Sacituzumab Govi...

1/19/2021Everest Medicines Announces Amended Agreement with Spero Therapeutics

1/8/2021Everest Medicines Announces CTA Approval for P3 Trial of Sacituzumab G...

12/8/2020Everest Med Recommended Breakthrough Therapy Designation for Nefecon i...

10/9/2020Everest Medicines Launches IPO in Hong Kong

9/15/2020Everest Reports on P1 Trial of Taniborbactam in Combo with Cefepime in...

6/4/2020Everest Medicines Completes $310 Million Series C Financing

4/23/2020Everest Med Approved for Clinical Trial of Sacituzumab in China

12/18/2019Everest Medicines Announces Chinese Clinical Trial Approval of Nefecon...

6/10/2019Everest Acquires China Rights to Kidney Disease Drug from Calliditas f...

5/3/2019Immunomedics and Everest Medicines Announce License Agreement for Saci...

Page:1/2 Total number of articles:35: [First][<<] [1] [2] [>>] [End]